No insider purchase over the last 90 days. The latest, by Firmenich A., was filed 09 Mar 2026.
+20 other insiders
Analysts rate DSM-Firmenich AG Buy (bullish), based on 2 analysts. Average price target: CHF 94.28.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 179 declarations
Between February 12 and March 4, 2026, 7 filers at DSM-Firmenich AG bought for EUR 50.6 million, which is all 11 purchases in the record (median EUR 1,449,000). Pometta A., member Board of Directors, bought EUR 28,211,803 on February 19, 2026; Firmenich P. and Firmenich A., also members of the Board of Directors, bought EUR 6,390,000 and EUR 6,320,000 on February 12, 2026.
The 37 sales are of another order: EUR 6.2 million in total, with a median of EUR 34,586. The largest date from June 29, 2026, with EUR 1,127,092 filed under the anonymous label of an executive member, and EUR 1,127,017 by A. van Impe, a person closely associated with a member of the Executive Committee.
The record has 91 filings, 88 in 2026 and 3 in 2025, published with a median delay of 0 days. Two anonymous filers, non-executive members of the board, filed 19 each, 8 of them sales and none a purchase. Over the last twelve months: 88 filings, 11 purchases and 37 sales. DSM-Firmenich AG, listed on Swiss stock exchange, belongs to the Chemicals sector and is worth CHF 24.4 billion.
Insider filings
Over the last 90 days, 30 filings published between 30 September and 21 October 2026: 15 sales for €859k. 15 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Leysen T. (chairman Board of Directors), sales of €354k; Mahieu C. (member Board of Directors), sales of €53k; Wortmann - Kool C.M. (member Board of Directors), sales of €49k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 22 October 2026 (UTC)
Headquarters: Kaiseraugst, Switzerland · Wikipedia article
Source: Wikidata (CC0).